Related references
Note: Only part of the references are listed.PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
Roza Zandi et al.
CLINICAL CANCER RESEARCH (2011)
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
J. M. R. Lambert et al.
ONCOGENE (2010)
FHIT: Doubts are Clear Now
Anjilna Wali
THESCIENTIFICWORLDJOURNAL (2010)
Specifically targeted gene therapy for small-cell lung cancer
Camilla L. Christensen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249
Hong Shi et al.
CARCINOGENESIS (2008)
PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
J. Shen et al.
ONCOGENE (2008)
Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells
Rong-Hua Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch
Gitanjali Jayachandran et al.
CANCER RESEARCH (2007)
Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells
Wu-Guo Deng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line
A. Cavazzoni et al.
CANCER LETTERS (2007)
PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax
Tao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Modulation of p53 transcriptional activity by PRIMA-1 and Pifithrin-α on staurosporine-induced apoptosis of wild-type and mutated p53 epithelial cells
J. F. Charlot et al.
APOPTOSIS (2006)
PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion
H Nahi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
Y Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
VJN Bykov et al.
ONCOGENE (2005)
Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells
M Nishizaki et al.
CANCER RESEARCH (2004)
The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression
L Roz et al.
ONCOGENE (2004)
Dissecting the genetic alterations involved in lung carcinogenesis
M Sanchez-Cespedes
LUNG CANCER (2003)
Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database
VJN Bykov et al.
CARCINOGENESIS (2002)
Reciprocal translocations in breast tumor cell lines:: Cloning of a t(3;20) that targets the FHIT gene
C Popovici et al.
GENES CHROMOSOMES & CANCER (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
The tumor spectrum in FHIT-deficient mice
N Zanesi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
FHIT gene therapy prevents tumor development in Fhit-deficient mice
KR Dumon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells
R Wu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
